🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

AMN Healthcare Services, Inc. AMN R2KR3KPHARMA

Healthcare · Medical Care Facilities · United States
https://www.amnhealthcare.com
Company Profile ↓
$33.80
+81.33% 1Y
Mkt Cap$1.31B
P/E-39.30
P/B1.95
52W High$36.60
52W Low$15.10
Book Value$18.44
EPS (TTM)$-0.86

Company Overview

AMN Healthcare Services, Inc. provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. It offers travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, allied staffing, crisis nurse staffing for critical staffing and rapid response nursing, and allied health professionals, such as skilled nursing facilities, rehabilitation clinics, schools, and pharmacies, as well as physician and advanced practice staffing, and revenue cycle solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists; and solutions for schools, including teletherapy platform, Televate, and qualified school speech-language pathologists, psychologists, nurses, social workers, and other care providers. In addition, it offers locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. Additionally, the company provides language services, vendor management systems, workforce optimization, and outsourced solutions. The company offers its services under the brands, including AMN Healthcare, Nursefinders, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is based in Dallas, Texas.

Why Investors Should Care

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $2.73B (-8.5% YoY); net profit $-95.70M.
  • Trailing 12 Months Year-on-year growth — revenue +99.9%.
  • 5-Year Trend Long-term compounding — revenue CAGR 8.3%.

Growth & Price Performance

Compounded Sales Growth

5 Years:8.32%
1 Year:99.90%

Stock Price Performance

1 Year:+81.33%
6 Months:+58.91%
3 Months:+6.66%
1 Month:+9.74%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 87% of range
$15.10 $36.60
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)49.21 · Neutral
Price Performance
1M+9.74%
3M+6.66%
6M+58.91%
1Y+81.33%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-39.30
Industry PE
25.17
Forward P/E
32.56
PEG Ratio
1.22
Book Value
$18.44
Price to Book
1.95
P/S
0.41
EV/EBITDA
4.86
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
8.32%
Profit 5Y
-
Revenue (YoY)
99.90%
Earnings (YoY)
-

Profitability & Returns

ROCE
2.19%
ROE
-4.54%
ROA
3.45%
Profit Margin
-0.95%
Op Margin
8.50%
Gross Margin
27.63%
EPS (Latest Qtr)
$0.53
EPS (TTM)
$-0.86

Balance Sheet & Liquidity

Debt/Equity
1.09
Quick Ratio
0.96
Current Ratio
1.09
Debt
$776.92M
Total Assets
$2.36B
Current Assets
$1.14B
Working Capital
$-32.24M

Ownership

Promoter Holding
0.97%
Chg in Prom Hold
0.00%
FII / Inst Holding
124.14%
Chg in FII Hold
0.03%

Financial Snapshot

Enterprise Value
$1.31B
Total Revenue (TTM)
$3.42B
EBITDA
$290.23M
Free Cash Flow
$671.52M
Operating Cash Flow
$739.24M
Shares Outstanding
38.79M
Gross Margin
27.63%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 AMN AMN Healthcare Services, Inc. R2KR3KPHARMA 33.80 -39.30 $1.31B 0.00% 2.19% -4.54% 8.32% -
2 LLY Eli Lilly and Company SPXR3KPHARMA 1,149.36 38.57 $1.02T 0.58% - 102.29% 7.20% 11.41%
3 JNJ Johnson & Johnson SPXR3KPHARMA 275.23 31.97 $663.28B 2.09% 14.88% 25.74% 2.43% 4.76%
4 ABBV AbbVie Inc. SPXR3KPHARMA 256.46 72.45 $453.19B 2.84% 10.47% -129.24% 1.75% -29.06%
5 MRK Merck & Co., Inc. SPXR3KPHARMA 150.33 120.26 $371.29B 2.65% - 34.70% 5.64% 10.01%
6 UNH UnitedHealth Group Incorporated SPXR3KPHARMA 397.14 25.54 $356.47B 2.33% 9.74% 14.15% 10.40% 5.43%
7 NVS Novartis AG PHARMA 159.99 24.20 $304.10B 3.03% 21.09% 30.35% 9.25% 26.22%
8 AZN AstraZeneca PLC NDXPHARMA 162.70 24.36 $252.33B 1.98% 15.97% 21.96% 9.82% 45.96%
9 AMGN Amgen Inc. NDXSPXR3KPHARMA 437.23 27.14 $235.98B 2.49% 13.95% 91.47% 5.51% 5.55%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue ------495.17M489.80M494.41M509.08M522.49M558.11M526.84M528.63M532.44M535.18M567.60M586.89M602.46M608.35M551.63M631.27M885.95M857.45M877.80M1.55B1.43B1.14B1.13B991.30M853.46M820.88M740.68M-689.53M658.17M634.50M748.23M1.38B673.24M
Cost of Revenue ----------------------------------491.41M461.78M450.08M553.10M1.01B-
Gross Profit 126.01M131.80M151.90M154.75M154.47M158.61M161.78M161.01M159.54M162.09M167.82M180.96M175.15M172.46M176.76M179.54M190.03M197.13M202.07M197.54M184.63M207.54M288.87M280.54M305.87M496.17M460.24M385.03M368.85M330.28M289.51M257.51M229.83M-198.12M196.40M184.41M195.13M368.84M205.88M
Operating Expenses ----------------------------------185.61M192.34M175.97M186.97M251.66M-
Operating Income 37.61M-47.31M47.88M46.68M-52.03M56.38M50.83M-55.20M54.81M42.63M-45.05M45.16M39.74M-35.74M38.40M46.46M-104.40M99.17M105.83M207.93M183.53M136.37M125.67M91.66M86.93M39.95M37.68M-12.51M4.06M8.44M8.16M117.17M26.91M
EBITDA ----------------------------------52.36M-83.83M87.25M45.35M152.83M-
Interest Expense ----------------------------------12.32M11.36M9.63M12.28M6.71M-
Pretax Income ----------------------------------183.00K-135.07M37.99M-4.16M110.46M-
Tax Provision ----------------------------------1.27M-18.87M8.70M3.53M48.29M-
Net Income 33.65M20.16M25.87M26.32M27.30M26.35M32.01M31.25M28.13M41.17M42.68M35.53M27.92M35.61M34.12M28.87M23.52M27.48M12.96M22.32M26.07M9.31M70.38M66.77M74.02M146.01M123.80M92.44M84.11M60.91M53.17M17.33M16.24M--1.09M-116.20M29.29M-7.70M62.17M21.16M
Diluted EPS 0.690.410.530.530.550.540.650.630.570.840.870.730.580.740.710.610.490.580.270.470.550.191.471.391.543.092.772.102.021.551.390.450.42--0.03-3.020.76-0.201.590.53

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 759.79M669.91M887.47M953.95M1.01B1.04B1.46B1.90B1.99B2.14B2.22B2.39B3.98B5.24B3.79B2.98B2.73B
Cost of Revenue -------------3.53B2.54B2.06B1.96B
Gross Profit 204.42M184.36M249.32M270.40M297.28M316.12M469.36M619.72M644.42M696.38M743.47M791.78M1.31B1.72B1.25B919.38M774.06M
Operating Expenses -------------1.07B903.35M799.59M740.89M
Operating Income -153.61M-43.78M37.65M53.34M65.50M67.90M128.88M191.63M212.44M202.83M176.91M149.26M478.00M647.10M346.23M119.78M33.17M
EBITDA -------------784.21M499.36M71.11M101.13M
Interest Expense -------------40.40M54.14M69.90M45.59M
Pretax Income -------------606.70M284.29M-172.57M-101.06M
Tax Provision -------------162.65M73.61M-25.59M-5.36M
Net Income -122.18M-51.99M-26.27M17.14M32.93M33.22M81.89M105.84M132.56M141.74M113.99M70.67M327.39M444.05M210.68M-146.98M-95.70M
Diluted EPS -3.75-1.49-0.570.370.690.691.682.152.682.912.401.486.819.905.36-3.85-2.48

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --562.11M535.63M517.39M604.29M680.73M880.43M1.19B1.25B1.49B1.93B2.35B-2.89B2.92B2.42B2.09B
Current Assets --------------1.09B841.68M594.91M545.38M
Cash & Equivalents 11.32M27.05M1.88M3.96M5.68M15.58M13.07M9.58M10.62M15.15M13.86M82.98M29.21M-64.52M32.94M10.65M33.97M
Inventory ------------------
Receivables --------------944.38M741.19M508.30M430.60M
Total Liabilities --380.28M375.90M335.27M386.55M424.15M532.57M737.50M691.43M853.73M1.19B1.53B-1.84B2.09B1.71B1.45B
Current Liabilities --117.89M140.05M109.53M143.09M178.29M251.02M274.79M265.27M307.27M378.11M422.96M-857.93M656.12M545.78M577.61M
Long Term Debt ---174.20M158.18M148.67M144.38M180.99M359.19M319.84M440.61M617.16M857.96M-843.50M1.30B1.06B767.05M
Total Debt --------------860.96M1.35B1.10B803.20M
Total Equity 284.13M170.84M153.46M135.66M182.11M217.74M256.58M347.86M449.38M562.53M638.99M736.74M819.68M-1.04B831.26M706.62M642.11M
Shares Outstanding --------------50.11M50.42M50.69M51.05M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 98.73M8.09M19.31M58.38M60.17M27.68M56.31M133.91M160.52M226.99M224.86M256.83M-653.73M372.17M320.42M269.46M
Investing Cash Flow -29.25M-6.85M-1.98M1.58M-49.20M-28.23M-116.08M-258.36M-35.36M-279.34M-291.82M-538.17M--170.71M-412.49M-79.94M4.30M
Financing Cash Flow -53.81M-26.45M-15.30M-58.17M-1.02M-2.10M56.20M126.29M-77.19M37.51M136.60M211.49M--591.87M10.73M-259.45M-295.89M
Capital Expenditure -3.79M-4.17M-4.65M-5.47M-9.05M-19.13M-27.01M-21.96M-26.53M-35.21M-35.22M-37.70M--80.92M-105.39M-80.89M-35.63M
Free Cash Flow 94.94M3.92M14.66M52.91M51.12M8.54M29.30M111.95M133.99M191.79M189.64M219.12M-572.81M266.78M239.53M233.83M
Net Change in Cash --------------108.84M-29.60M-18.97M-22.13M
Share Buybacks -----0013.26M20.16M67.01M18.70M02.69M576.77M424.74M00

Ratios (Annual)

Figures in %.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % 26.9%27.5%28.1%28.3%29.4%30.5%32.1%32.6%32.4%32.6%33.5%33.1%32.9%32.7%33.0%30.8%28.3%
Operating Margin % -20.2%-6.5%4.2%5.6%6.5%6.6%8.8%10.1%10.7%9.5%8.0%6.2%12.0%12.3%9.1%4.0%1.2%
Net Margin % -16.1%-7.8%-3.0%1.8%3.3%3.2%5.6%5.6%6.7%6.6%5.1%3.0%8.2%8.5%5.6%-4.9%-3.5%
ROE % -71.5%-33.9%-19.4%9.4%15.1%12.9%23.5%23.6%23.6%22.2%15.5%8.6%-42.5%25.3%-20.8%-14.9%
ROCE % --9.9%9.5%13.1%14.2%13.5%20.5%21.0%21.5%17.1%11.4%7.7%-31.9%15.3%6.4%2.2%

Shareholding Pattern

Insiders
0.97%
Institutions
124.14%
Public Float
125.35%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 17.15% 6.64M $229.99M
2 Morgan Stanley 5.89% 2.28M $79.02M
3 Vanguard Capital Management LLC 4.44% 1.72M $59.51M
4 State Street Corporation 4.37% 1.69M $58.66M
5 Boston Partners 4.32% 1.67M $57.97M
6 Allianz Asset Management GmbH 3.62% 1.40M $48.57M
7 Arrowstreet Capital, Limited Partnership 3.59% 1.39M $48.19M
8 Vanguard Portfolio Management LLC 3.33% 1.29M $44.59M
9 Dimensional Fund Advisors LP 3.31% 1.28M $44.43M
10 Two Sigma Investments, LP 2.99% 1.16M $40.10M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for AMN

Yahoo Finance Mon, 07 Sep 2026

Dassault Aviation: Reduction of capital by cancellation of treasury shares

Reduction of capital by cancellation of treasury shares On July 22, 2026, the Board of directors of Dassault Aviation decided to reduce the share capital of the company by cancelling 519,137 treasury shares held in registered form, represen…

Yahoo Finance hu, 03 Sep 2026

3 Reasons to Avoid AMN and 1 Stock to Buy Instead

The past six months have been a windfall for AMN Healthcare Services’s shareholders. The company’s stock price has jumped 59.3%, hitting $33.44 per share. This was partly due to its solid quarterly results, and the run-up might have investo…

Yahoo Finance hu, 03 Sep 2026

Dassault Aviation: Total number of shares and voting rights - 31 08 26

DASSAULT AVIATION French corporation (société anonyme) with a share capital of 62,170,196.80 euros Headquarters: 78, quai Marcel Dassault 92210 SAINT-CLOUD 712 042 456 RCS Nanterre Information concerning the total number of voting rights an…

Yahoo Finance Wed, 26 Aug 2026

Zacks.com featured highlights Centene, Archer-Daniels-Midland, Avnet, Arrow and AMN

Centene, Archer-Daniels-Midland, Avnet, Arrow and AMN have been highlighted in this Screen of The Week article.

Yahoo Finance Wed, 26 Aug 2026

AMN Healthcare Services (AMN) Stock May Trade At A Discount On Its 124% Run

AMN Healthcare Services has surged 124.3% year to date, while valuation checks send mixed signals, with a Discounted Cash Flow (DCF) intrinsic value estimate implying the stock trades at a 21.6% discount and market multiples pointing the ot…

Yahoo Finance ue, 25 Aug 2026

Dassault Aviation: Total number of shares and voting rights - 31 07 26

DASSAULT AVIATION French corporation (société anonyme) with a share capital of 62,170,196.80 euros Headquarters: 78, quai Marcel Dassault 92210 SAINT-CLOUD 712 042 456 RCS Nanterre Information concerning the total number of voting rights an…

AMN — Frequently Asked Questions

What is the current share price of AMN Healthcare Services, Inc. (AMN)?

As of 2026-09-07 16:24 PDT, AMN Healthcare Services, Inc. (AMN) trades at $33.80 on NYSE. Its 52-week range is $15.10 to $36.60.

What is the market capitalisation of AMN?

AMN Healthcare Services, Inc. (AMN) has a market capitalisation of $1.31B on NYSE.

What is the P/E ratio of AMN?

AMN trades at a trailing price-to-earnings (P/E) ratio of -39.30. The industry average P/E is 25.17. Its price-to-book (P/B) ratio is 1.95.

What is the return on equity (ROE) of AMN?

AMN has a return on equity (ROE) of -4.54%. Its return on capital employed (ROCE) is 2.19%.

Is AMN a good stock to buy?

This page provides a data-driven analysis of AMN Healthcare Services, Inc. (AMN), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space